用表达靶向 EphA2 CAR 的 mRNA 工程化 NK 细胞增强抗肉瘤免疫
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
该研究为 EphA2 靶向 CAR-NK 细胞治疗在一系列儿童肉瘤中的临床评价提供了基础依据。
50.3分
★★★☆☆
FRONTIER PAPERS
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
该研究为 EphA2 靶向 CAR-NK 细胞治疗在一系列儿童肉瘤中的临床评价提供了基础依据。
Clinical utility of CAR T cell therapy in brain tumors: Lessons learned from the past, current evidence and the future stakes.
嵌合抗原受体(CAR)T细胞疗法在血液系统恶性肿瘤中前所未有的临床成功,促使研究人员研究其在实体瘤中的作用。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。